Ivosidenib Alternatives Compared
| Ivosidenib | Tibsovo (ivosidenib) | Durvalumab |
|
|---|
| Ivosidenib | Tibsovo (ivosidenib) | Durvalumab |
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Biliary Tract Tumor, Acute Myeloid Leukemia, Myelodysplastic Syndrome. Ivosidenib may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Biliary Tract Tumor, Acute Myeloid Leukemia, Myelodysplastic Syndrome. Tibsovo may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Non Small Cell Lung Cancer, Small Cell Lung Cancer, Biliary Tract Tumor, Bladder Cancer, Hepatocellular Carcinoma, Endometrial Cancer. Durvalumab may also be used for purposes not... View more |
Related suggestions Biliary Tract Tumor
|
|||||||
| More about Ivosidenib | More about Tibsovo (ivosidenib) | More about Durvalumab | ||||||||
| Ratings & Reviews | ||||||||||
|
Be the first to share your experience with this drug. |
Be the first to share your experience with this drug. |
Durvalumab has an average rating of 7.5 out of 10 from a total of 8 ratings on Drugs.com. 63% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||
|
View all Ivosidenib side effects |
View all Tibsovo side effects |
View all Durvalumab side effects |
||||||||
| Drug Class | ||||||||||
| Generic Availability | ||||||||||
|
N/A |
N/A |
|||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Tibsovo prices |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
||||||||
| Dosage Forms | ||||||||||
|
N/A |
|
N/A |
||||||||
| Brand Names | ||||||||||
| Tibsovo |
N/A |
Imfinzi | ||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||
|
129 hours |
129 hours |
408 hours |
||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||
| Pregnancy Category | ||||||||||
|
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
Summary unavailable. See the full pregnancy warnings document. |
||||||||
| Drug Interactions | ||||||||||
|
A total of 583 drugs are known to interact with Ivosidenib:
|
A total of 583 drugs are known to interact with Tibsovo:
|
A total of 631 drugs are known to interact with Durvalumab:
|
||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||
|
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||||||||
| Disease Interactions | ||||||||||
| First Approval Date | ||||||||||
|
July 20, 2018 |
July 20, 2018 |
May 01, 2017 |
||||||||
| WADA Class View classifications | ||||||||||
|
N/A |
N/A |
N/A |
||||||||
| More Information | ||||||||||
| Patient Resources | ||||||||||
| Professional Resources | ||||||||||
| Related Treatment Guide | ||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.